Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that it has received funding […]
Labcon Awarded $59.3 Million U.S Government Contract to Increase Domestic Production of Pipette Tips and Tubes
Labcon North America, the world’s leading manufacturer of Earth Friendly® laboratory disposables, announced today a $59.3 million contract […]
Leucid Bio Raises £11.5M in Series A Financing to Develop Next Generation of Innovative Chimeric Antigen Receptor T cell (CAR-T) Therapies
Leucid Bio (“Leucid” or the “Company”), a biotech company pioneering next-generation cell therapies for hard-to-treat […]
ScienceIO Launches with $8 Million Seed to Fix Healthcare's Data Problem
ScienceIO, the data science company transforming healthcare, emerged from stealth mode today with $8 million in seed […]
DeepSight ™ Technology Announces $25M Series A Funding Round
DeepSight ™ Technology has announced a $25 million Series A led by Deerfield Management Company, a healthcare investment […]
Babylon Secures New $200m Sustainability-Linked Investment to Fuel Rapid Growth Plan
Babylon Holdings Limited (“Babylon“), one of the world’s fastest-growing digital healthcare companies, today announced that […]
Legend Capital Leads ForQaly Medical's Series B Financing
ForQaly Medical (hereinafter referred to as “ForQaly”), located in Shanghai Zhangjiang International Medical Zone, is […]
Bayer to Invest Over €400 Million to Increase Access to Modern Contraception
Bayer today announced to invest over €400 million, reinforcing its commitment to providing 100 million […]
CoreBone Raises $3.7 Million Investment to Commercialize its Bioactive Bone Graft Material for Dental and Orthopedic Treatments & Expand Activity in China
CoreBone, a company that produces bioactive, coral-based bone graft material, announced that it has completed an […]
Advent France Biotechnology Launches its Second Fund with a First Close at €86M ($102M)
Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, today announces the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more